New approaches to the treatment of diabetes

Section 1: Understanding of Diabetes: Modern View

  1. 1 Epidemiology and prevalence of diabetes:
    • Global trends in the prevalence of diabetes 1 and 2 types.
    • The influence of geographical, ethnic and socio-economic factors.
    • Predictable changes in prevalence in the future.
    • Statistics on Russia and other countries.
  2. 2 Classification of diabetes: updated system:
    • Type 1 diabetes: autoimmune destruction of pancreatic β cells.
    • Type 2 diabetes: insulin resistance and violation of insulin secretion.
    • Gestational diabetes: diabetes that occurs during pregnancy.
    • Other specific types of diabetes: Mody (Maturity-Oneset Diabetes of the Young), Lada (Lattoimmune Diabetes in Adults), diabetes caused by drugs or other diseases.
    • Advantages and disadvantages of the existing classification.
  3. 3 Pathophysiology of diabetes: molecular mechanisms:
    • The role of insulin in the regulation of glucose metabolism.
    • Molecular mechanisms of insulin resistance.
    • Violation of the secretion of insulin β-cells of the pancreas.
    • The role of other hormones (glucagon, amilin, increetins) in the pathogenesis of diabetes.
    • The influence of genetic factors and environmental factors.
    • The role of chronic inflammation in the development of insulin resistance and type 2 diabetes.
    • Glucozotoxicity and lipotoxicity: mechanisms for damage to β-cells and other organs.
  4. 4 Diabetes diagnostics: modern criteria and methods:
    • Diabetes diagnosis criteria: glucose level in plasma on an empty stomach, glucose level after load, the level of glycated hemoglobin (HBA1C).
    • Advantages and disadvantages of various diagnostic methods.
    • Diabetes diagnostics algorithms 1 and 2 types.
    • Diagnosis of gestational diabetes.
    • Identification of persons with a high risk of development of diabetes (pre -Abet).
    • Continuous glucose monitoring (CGM): Principles of work, advantages and disadvantages.
    • New diagnostic methods: metabolism analysis, genetic testing.
  5. 5 Diabetes complications: from microsyuded to macro -vascular:
    • Micro -vascular complications: retinopathy, nephropathy, neuropathy.
    • Macro -vascular complications: coronary heart disease, stroke, peripheral arterial diseases.
    • Other complications: diabetic foot, gastroparesis, erectile dysfunction.
    • Mechanisms for the development of diabetes complications.
    • Risk factors for the development of complications.
    • The role of glycemic control in the prevention of complications.
    • Modern approaches to the prevention and treatment of complications of diabetes.

Section 2: Traditional approaches to the treatment of diabetes: update and optimization

  1. 6 Dietotherapy: The basis for the treatment of diabetes:
    • An individual approach to diet therapy.
    • The role of carbohydrates, fats and proteins in a diet in diabetes.
    • Glycemic index and glycemic load of products.
    • Mediterranean diet, dash diet and other diets recommended for diabetes.
    • The role of dietary fibers.
    • Sweeteners and their use in diabetes.
    • Modern recommendations for nutrition for diabetes 1 and 2 types.
    • Personalized dietary plans based on continuous glucose monitoring.
  2. 7 Physical activity: an indispensable component of treatment:
    • The effect of physical activity on blood glucose and insulin resistance.
    • Recommendations on the type and intensity of physical activity.
    • An individual approach to physical activity planning.
    • Advantages of aerobic and anaerobic exercises.
    • The role of physical activity in the prevention of diabetes complications.
    • Monitoring of glucose levels during physical activity.
    • Recommendations for patients with diabetes complications.
  3. 8 Medicine therapy: Modern drugs and strategies:
    • Insulin therapy: types of insulin, insulin therapy schemes, pompom insulin therapy.
      • Long -action basal insulins: Glargin, Detemir, Degludek.
      • Bolosal insulins of short and ultra -short action: Lizpr, Aspart, Glulizin, human insulin.
      • Mixed insulins.
      • The modes of multiple injections of insulin (MDI) and constant subcutaneous insulin infusion (CSII).
      • Insulin pumps: advantages, disadvantages and modern models.
      • Inhalation insulin.
    • Metformin: mechanism of action, indications, contraindications, side effects.
    • Derivatives of sulfonylings: mechanism of action, indications, contraindications, side effects.
    • Glinides (meglitinides): mechanism of action, indications, contraindications, side effects.
    • Thiazolidindo (grocery and ginger): mechanism of action, indications, contraindications, side effects.
    • Dipeptidylpeptidase-4 (DPP-4) inhibitors: mechanism of action, readings, contraindications, side effects.
    • Glucagono-like peptide-1 (GPP-1) receptors: mechanism of action, readings, contraindications, side effects.
      • Exenatide, luraglutide, semaglutide, dulaglutide.
      • Advantages of weight loss and cardiovascular risks.
    • Inhibitors of sodium-glucose coter carrier 2 (SGLT2): mechanism of action, readings, contraindications, side effects.
      • Dapagriflozin, émpagriflozin, kanagriflozin.
      • Advantages in reducing cardiovascular and renal risks.
    • Combined therapy: rational combinations of drugs.
    • An individual approach to the choice of drug therapy.
    • Type 2 diabetes treatment algorithms.
    • New oral drugs and injection forms.
  4. 9 Self -control glucose: the key to successful treatment:
    • The importance of self -control of the level of glucose in the blood.
    • Self -control methods: glucometers, continuous glucose monitoring systems (CGM).
    • Interpretation of the results of self -control.
    • Adaptation of treatment based on the results of self -control.
    • Patient training is self -control.
    • Telemedicine and self -control.
  5. 10 Patient training: Expanding opportunities:
    • The importance of teaching patients with diabetes treatment.
    • Patient training programs.
    • The role of nurses and other specialists in patient training.
    • The use of modern technologies (websites, mobile applications) for teaching patients.
    • Training of relatives and close patients.
    • Psychological support of patients.

Section 3: Innovative approaches to the treatment of diabetes: Revolution in therapy

  1. 11 Artificial pancreas: automated glucose control:
    • The principles of artificial pancreas.
    • Components of artificial pancreas: glucose sensor, insulin pump, control algorithm.
    • Various types of artificial pancreas: a closed circuit, a hybrid closed circuit.
    • Advantages and disadvantages of artificial pancreas.
    • Clinical tests of artificial pancreas.
    • Prospects for the use of artificial pancreas in patients with type 1 diabetes.
    • The use of artificial pancreas in patients with type 2 diabetes.
    • Commercially available systems of artificial pancreas.
  2. 12 Cell therapy: restoration of β cells:
    • Transplantation of β-cells of the pancreas: sources of β-cells, transplantation methods, immunosuppression.
    • Induction of regeneration of β-cells: the use of growth factors, kinase inhibitors, gene therapy.
    • Stem cell transplantation: differentiation of stem cells to β-cells, immune compatibility.
    • Immunotherapy of type 1 diabetes: prevention of autoimmune destruction of β-cells.
    • Clinical tests of cell therapy.
    • Advantages and disadvantages of cell therapy.
    • Ethical aspects of cell therapy.
    • Prospects for cell therapy in the treatment of type 1 diabetes.
  3. 13 Gene therapy: modification of genes associated with diabetes:
    • General diabetes therapy of type 1: delivery of genes encoding insulin to liver or muscles.
    • Genetic therapy of type 2 diabetes: modification of genes involved in the regulation of glucose and insulin resistance metabolism.
    • The use of viral vectors for genes delivery.
    • CRISPR/CAS9 technology for editing the genome.
    • Clinical trials of genetic therapy.
    • Advantages and disadvantages of genetic therapy.
    • Ethical aspects of genetic therapy.
    • Prospects for genetic therapy in the treatment of diabetes.
  4. 14 Type 1 diabetes immunotherapy: prevention of autoimmune attacks:
    • The mechanisms of autoimmune destruction of β-cells in type 1 diabetes.
    • Targets for immunotherapy: T cells, B cells, antigen-representative cells.
    • Various approaches to immunotherapy: antibodies to immune cells, immunomodulators, cellular immunotherapy.
    • Clinical tests of immunotherapy.
    • Advantages and disadvantages of immunotherapy.
    • Prospects for the use of immunotherapy to prevent the development of type 1 diabetes.
  5. 15 Microbiota and diabetes: new connection:
    • The composition of the intestinal microbiots in patients with diabetes and healthy people.
    • The effect of microbiota on glucose metabolism and insulin resistance.
    • The mechanisms of the interaction of microbiota and the body of the owner.
    • Modulation opportunities microbiota: diet, probiotics, prebiotics, transplantation of fecal microbiota.
    • Clinical tests of modulation microbiota.
    • The advantages and disadvantages of module microbiota.
    • Prospects for the use of microbiotic modulation in the treatment of diabetes.

Section 4: auxiliary and alternative methods of treatment of diabetes

  1. 16 Traditional medicine and alternative methods:
    • The use of medicinal plants and herbs in traditional medicine.
    • Ayurveda, traditional Chinese medicine and other systems.
    • Acupuncture, yoga and other methods.
    • The importance of consulting a doctor before using alternative methods.
    • Scientific research of the effectiveness of alternative methods.
    • Potential risks and side effects.
  2. 17 Psychological support and stress management:
    • The effect of stress on the level of glucose in the blood.
    • Stress management methods: meditation, relaxation, cognitive-behavioral therapy.
    • Support groups for patients with diabetes.
    • The role of a psychologist in the treatment of diabetes.
  3. 18 Telemedicine and remote monitoring:
    • Advantages of telemedicine for patients with diabetes.
    • Remote counseling, glucose level monitoring, patient training.
    • The use of mobile applications and websites.
    • Integration of telemedicine into the healthcare system.
    • The effectiveness of telemedicine in improving glycemic control.

Section 5: Prevention of diabetes and prediabetes

  1. 19 Type 1 diabetes prevention: Modern research:
    • Risk factors for the development of diabetes of type 1.
    • Primary prevention studies: prevention of autoimmune destruction of β cells.
    • Secondary prevention studies: slowdown in the progression of the autoimmune process.
    • Using immunomodulators and other drugs.
    • Genetic testing to identify persons with high risk.
    • Dietary factors and their role in the prevention of type 1 diabetes.
  2. 20 Type 2 diabetes prevention: Life change change and medical prevention:
    • Risk factors for the development of diabetes of type 2.
    • Change in lifestyle: diet, physical activity, weight loss.
    • Drug prevention: metformin, akarbose, thiazolidindo.
    • Type 2 diabetes prevention programs.
    • Assessment of the effectiveness of prevention programs.
    • The role of the healthcare system in the prevention of type 2 diabetes.
    • Strategies to reduce the prevalence of type 2 diabetes.
  3. 21 Pre -Abet: Early detection and intervention:
    • Criteria for the diagnosis of pre -ibet.
    • The value of the early detection of pre -ibet.
    • Change in lifestyle with pre -Abet.
    • Medication therapy for pre -ABET.
    • Diabetes prevention programs in people with pre -Aibet.
    • Long -term results of prevention programs.
  4. 22 Prevention Gestative Diabetes:
    • Risk factors for the development of gestational diabetes.
    • Screening for gestational diabetes.
    • Diet therapy and physical activity in gestational diabetes.
    • Insulin therapy for gestational diabetes.
    • Prevention of type 2 diabetes after gestational diabetes.

Section 6: Future of treatment of diabetes: prospects and challenges

  1. 23 Personalized medicine in the treatment of diabetes:
    • An individual approach to diagnosis and treatment of diabetes.
    • Genetic testing to determine the risk of diabetes and the choice of optimal therapy.
    • Pharmacogenomy: the effect of genetic factors on the effectiveness and safety of drugs.
    • Analysis of metabolism and proteoma to detect diabetes biomarkers.
    • The use of big data and artificial intelligence to develop personalized treatment strategies.
  2. 24 Nanotechnology in the treatment of diabetes:
    • Nanosensers for continuous monitoring of glucose levels.
    • Nanoparticles for the delivery of drugs to β-cells of the pancreas.
    • Artificial β-based nanomaterials.
    • Nanotherapy for the treatment of diabetes complications.
  3. 25 Artificial intelligence and big data in the treatment of diabetes:
    • The use of artificial intelligence to analyze the data of continuous glucose monitoring.
    • Development of algorithms for automatic dose correction of insulin.
    • The use of large data to identify risk factors for the development of diabetes and develop prevention programs.
    • Artificial intelligence for the diagnosis of diabetes and its complications.
  4. 26 Ethical and social aspects of new methods of treatment of diabetes:
    • The availability of new treatment methods for all patients.
    • Confidentiality of genetic information.
    • Ethical issues related to genetic therapy and cell therapy.
    • The influence of new technologies on the relationship between the doctor and the patient.
  5. 27 The role of the state and the healthcare system in the development of new methods of treatment of diabetes:
    • Financing of scientific research.
    • Regulation of new treatment methods.
    • Integration of new technologies into the healthcare system.
    • Education of medical workers with new treatment methods.
    • Information of the population about new treatment methods.

Section 7: Complications of diabetes: advanced management and treatment methods

  1. 28 Diabetic retinopathy: modern approaches to treatment:
    • Pathogenesis of diabetic retinopathy.
    • Classification of diabetic retinopathy.
    • Methods of diagnosis of diabetic retinopathy: ophthalmoscopy, fluorescent angiography, optical coherent tomography (OKT).
    • Laser coagulation of the retina.
    • Intravitreal injections of VEGF inhibitors (vascular endothelial growth factor).
      • Ranumab, Afshebizumab, Bevatumab.
    • Surgical treatment: vitrectomy.
    • New treatment methods: gene therapy, cell therapy.
    • Prevention of diabetic retinopathy: monitoring the level of glucose in the blood, blood pressure and lipids.
  2. 29 Diabetic nephropathy: advanced methods of treatment and prevention:
    • Pathogenesis of diabetic nephropathy.
    • Stages of diabetic nephropathy.
    • Methods of diagnosis of diabetic nephropathy: urine analysis for microalbuminuria, determining the speed of glomerular filtration (SCF), kidney biopsy.
    • ACE inhibitors (angiotenzinzinoping enzyme) and Angiotensin II receptor blockers (sconces).
    • SGLT2 inhibitors: kidney protection in diabetes.
    • Control of blood pressure.
    • Diet therapy: restriction of protein and salt consumption.
    • Placement of renal therapy: hemodialysis, peritoneal dialysis, kidney transplantation.
    • New treatment methods: antifibrose drugs, cell therapy.
    • Prevention of diabetic nephropathy: monitoring the level of glucose in the blood, blood pressure and lipids, early detection and treatment.
  3. 30 Diabetic neuropathy: modern approaches to treatment:
    • Pathogenesis of diabetic neuropathy.
    • Classification of diabetic neuropathy: peripheral, autonomous, focal.
    • Symptoms of diabetic neuropathy: pain, numbness, tingling, weakness, digestive disorders, orthostatic hypotension, erectile dysfunction.
    • Methods of diagnosis of diabetic neuropathy: neurological examination, electroneuromyography (ENMG), quantitative sensory testing (KST).
    • Monitoring the level of glucose in the blood.
    • Medicines for the treatment of pain neuropathy: antidepressants (amitriptyin, dulcesetin), anticonvulsants (Gabapentin, Pregabalin), opioid analgesics (tramadol).
    • Local treatment of pain neuropathy: capsaicin, lidocaine.
    • Treatment of autonomous neuropathy: diet correction, drugs for the treatment of gastroparesis, orthostatic hypotension and erectile dysfunction.
    • New treatment methods: gene therapy, cell therapy.
    • Physiotherapy and rehabilitation.
  4. 31 Diabetic foot: an integrated approach to treatment and prevention:
    • Risk factors for the development of diabetic foot: neuropathy, angiopathy, foot deformation, injury, infection.
    • Classification of lesions of the diabetic foot: neuropathic ulcer, ischemic ulcer, neuroichemic ulcer.
    • Diabetic foot diagnostic methods: examination of the foot, sensitivity assessment, determination of pulsation of arteries, ankle-breed index (LPI), transcetic oxymmetry (TSRO2), angiography.
    • Care for the feet: regular inspection, washing, moisturizing, circumcision of nails, wearing suitable shoes.
    • Unloading of the affected limb: the use of orthosis, crutches, wheelchair.
    • Surgical treatment: removal of necrotic tissues, abscess drainage, revascularization (angioplasty, shunting).
    • Antibiotic therapy for infections.
    • Local treatment of ulcers: cleaning wounds, using modern wound coatings, healing stimulation.
    • Reconstructive operations to correct the deformation of the foot.
    • Prevention of diabetic foot: patient training, regular examination of the feet, wearing suitable shoes, control of blood glucose, and smoking refusal.
  5. 32 Cardiovascular diseases in diabetes: Modern strategies for treatment and prevention:
    • Increased risk of cardiovascular diseases in patients with diabetes.
    • Pathogenesis of cardiovascular diseases in diabetes.
    • Risk factors for cardiovascular diseases: dyslipidemia, arterial hypertension, obesity, smoking, family history.
    • Screening for cardiovascular diseases: electrocardiogram (ECG), echocardiography, stress test, coronary angiography.
    • Change in lifestyle: diet, physical activity, rejection of smoking.
    • Drug therapy: anti-agents (aspirin, clopidogrel), statins, ACE inhibitors, angiotensin II receptors, beta-blockers, SGLT2 inhibitors, GPP-1 agonists.
    • Myocardium revascularization: angioplasty, shunting.
    • Treatment of heart failure.
    • Prevention of cardiovascular diseases: monitoring the level of glucose in the blood, blood pressure and lipids, refusal of smoking, a healthy lifestyle.

Section 8: Special groups of patients with diabetes

  1. 33 Diabetes in children and adolescents: unique problems and solutions:
    • Features of the diagnosis and treatment of diabetes in children and adolescents.
    • Type 1 diabetes in children and adolescents: insulin therapy, pompom insulin therapy, self -control of the level of blood glucose, diet, physical activity, psychological support.
    • Type 2 diabetes in children and adolescents: risk factors, lifestyle changes, metformin, insulin therapy.
    • Gestational diabetes in adolescents: Features of pregnancy.
    • The transition from children’s to adult healthcare.
    • Psychosocial aspects of diabetes in children and adolescents: stigmatization, depression, anxiety.
    • The role of the family in the treatment of diabetes in children and adolescents.
    • Using modern technologies: continuous glucose monitoring, insulin pumps with a closed contour.
    • Prevention of diabetes complications.
  2. 34 Diabetes in the elderly: special approaches to treatment:
    • Features of diagnosis and treatment of diabetes in the elderly.
    • The goals of glycemic control in the elderly: reducing the risk of hypoglycemia, improving the quality of life.
    • The choice of drugs in the elderly: accounting for concomitant diseases and drug interactions.
    • Diet therapy and physical activity in older people: individual approach, accounting of physical restrictions.
    • Assessment of cognitive functions and functional status.
    • Prevention of falls and injuries.
    • Treatment of diabetes complications.
    • The role of home departure and social support.
    • Palliative assistance in the terminal stages of diabetes.
  3. 35 Diabetes and pregnancy: Optimal management for the health of the mother and child:
    • Pregnancy planning in women with diabetes.
    • Proofing preparation: control of the level of glucose in the blood, blood pressure and lipids, rejection of smoking and alcohol, intake of folic acid.
    • Pregnancy in type 1 diabetes: insulin therapy, self -control of the level of glucose in the blood, diet, physical activity, monitoring of the condition of the fetus.
    • Pregnancy in type 2 diabetes: metformin, insulin therapy, self -control of the level of glucose in the blood, diet, physical activity, monitoring of the condition of the fetus.
    • Gestational diabetes: diagnosis, diet therapy, physical activity, insulin therapy, monitoring of the condition of the fetus.
    • Childbirth in women with diabetes: the choice of the method of delivery, monitoring the level of glucose in the blood during childbirth, monitoring the state of the newborn.
    • The postpartum period: control of the level of glucose in the blood, return to the previous therapy, breastfeeding, prevention of type 2 diabetes.
    • Complications of pregnancy in diabetes: preeclampsia, premature birth, fetal macrosomia, shoulder dystos, neonatal hypoglycemia.
  4. 36 Diabetes and mental disorders: an integrated approach to treatment:
    • The increased prevalence of mental disorders in patients with diabetes: depression, anxiety, eating disorders.
    • The influence of mental disorders on the control of the level of glucose in the blood and commitment to treatment.
    • Methods of diagnosing mental disorders in patients with diabetes: screening, clinical interview.
    • Treatment of depression and anxiety: psychotherapy, antidepressants, anxiolytics.
    • Treatment of eating disorders: psychotherapy, diet therapy, drug therapy.
    • Psychological support and training of patients.
    • An integrated approach to the treatment of diabetes and mental disorders: cooperation between an endocrinologist, psychiatrist and psychologist.
  5. 37 Diabetes and HIV infection: joint management:
    • Increased prevalence of diabetes in patients with HIV infection.
    • The effect of antiretroviral therapy on glucose metabolism.
    • Features of diagnosis and treatment of diabetes in patients with HIV infection.
    • Drug interactions between drugs for the treatment of diabetes and HIV infection.
    • Prevention of diabetes in patients with HIV infection: change in lifestyle, screening for diabetes.
    • Joint conducting patients with diabetes and HIV infection: cooperation between an endocrinologist and infectious disease specialist.

Section 9: Research and the Future of Diabetology

  1. 38 New targets for the treatment of diabetes:
    • The study of new molecular targets for the development of drugs.
    • The role of inflammation in the pathogenesis of diabetes.
    • The effect of intestinal microbiots on glucose metabolism.
    • The study of genetic factors affecting the development of diabetes.
    • Development of new drugs to improve insulin secretion, increase insulin sensitivity and reduce blood glucose.
  2. 39 Clinical tests of new methods of diabetes:
    • Review of current clinical tests of new methods of treatment of diabetes.
    • Testing of new drugs, devices and technologies.
    • The results of clinical trials and their impact on clinical practice.
    • Patients of patients in clinical trials: advantages and risks.
  3. 40 Trends and forecasts in the treatment of diabetes:
    • The development of personalized medicine in the treatment of diabetes.
    • The use of artificial intelligence and large data to improve glycemic control.
    • Development of new insulin delivery methods.
    • Cellular and genetic therapy of diabetes.
    • Prevention of diabetes and its complications.
    • Improving the quality of life of patients with diabetes.

This detailed outline provides a comprehensive framework for a 100,000-word article on new approaches to diabetes treatment. Each section can be expanded upon with in-depth explanations, research findings, clinical data, and expert opinions to reach the target word count while maintaining high-quality content. Remember to cite your sources meticulously and ensure all information is accurate and up-to-date. This outline prioritizes clarity, comprehensiveness, and SEO relevance to ensure the article is both informative and easily discoverable.

Leave a Reply

Your email address will not be published. Required fields are marked *